๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of cytosine arabinoside maintenance in acute nonlymphoblastic leukemia

โœ Scribed by P. N. Grozea; Dr. R. H. Bottomley; M. T. Shaw; H. Tu; R. E. Chanes; P. T. Condit


Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
394 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cytosine arabinoside in acute leukemia o
โœ D. G. Traggis; A. Dohlwitz; L. Das; N. Jaffe; W. C. Moloney; T. C. Hall ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB ๐Ÿ‘ 1 views
Low-dose cytosine arabinoside in the mye
โœ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 351 KB ๐Ÿ‘ 1 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Short courses of cytosine arabinoside an
โœ H. Ekert; J. H. Colebatch; R. N. Matthews ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 488 KB ๐Ÿ‘ 1 views

Courses of cytosine arabinoside followed by L-asparaginase were administered for 4 days each to 17 children with previously treated acute lymphatic leukemia, at 14to 27-day intervals. Complete or partial remission occurred in 81% of patients after the third or fourth course of therapy. Rlaintenance